Richter Gedeon stock: Consensus sets HUF 13,214.57 target for Richter Gedeon stock

Published on 10/19/2026 at 15:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Budapest closed Richter Gedeon at HUF 12,470 on October 16, 2026. Richter Gedeon stock costs EUR 34.85 on October 19, 2026 at 3:41 p.m. CEST.

Analyst target and price

Investing.com lists a HUF 13,214.57 average target from seven analysts, 5.97 percent above the Budapest close.
Richter Gedeon closed at HUF 12,470 on October 16, 2026, down 1.89 percent with 188,509 shares traded.
Richter Gedeon stock was trading at EUR 34.85 at Lang & Schwarz on October 19, 2026 at 3:41 p.m. CEST.

Richter Gedeon, HU0000123096, Illustration mit AI erstellt.

Investing.com lists a 12-month average target of HUF 13,214.57 for Richter Gedeon, based on seven analysts. The target is 5.97 percent above the HUF 12,470 Budapest close cited on the same page, giving investors a dated valuation reference in the company's home currency.

Richter Gedeon stock was trading at EUR 34.85 at Lang & Schwarz on October 19, 2026 at 3:41 p.m. CEST. The quote was above the EUR 34.31 level shown in the Lang & Schwarz price feed, but the article uses only the dated market price because a dated Xetra closing value was not established.

Budapest price stays below yearly high

On October 16, 2026, Richter Gedeon closed at HUF 12,470 in Budapest, down 1.89 percent on the session, according to Patria. The same page records 188,509 shares traded, a day high of HUF 12,810 and a day low of HUF 12,460.

Patria's market history places the 52-week range at HUF 9,380 to HUF 13,570. The Budapest share was 8.11 percent below that high and 32.94 percent above the low on October 16, while its year-to-date performance stood at 26.41 percent.

Pharmaceutical profile supports the comparison

Richter Gedeon develops and manufactures pharmaceutical products across central nervous system, women's healthcare, cardiovascular and over-the-counter categories. Its business also includes general medicines and biotechnology, giving the stock exposure to both established products and biosimilar development.

The market data place Richter Gedeon's HUF 12,470 close below the seven-analyst average target of HUF 13,214.57, while the current euro quotation provides a separate view for investors trading through German venues. The two currencies should be read independently rather than combined into one return calculation.

Company details and market links

Richter Gedeon trades in Budapest under the RICHTER.BD symbol and belongs to the healthcare and pharmaceutical industry. The company was founded in 1901 and is headquartered in Budapest, Hungary.

The further course of trading is shown by the continuously updated real-time quote of Richter Gedeon stock.